German Center for Infection Research (DZIF) – Medical doctor stipend
BMBF Africa: TB Sequel II Comorbidities, risk factors and long-term sequelae defining the individual outcome and public health impact of TB disease, -2025
Leibniz Research Campus EVOLungIron metabolism genes in the interaction between microbiota, host and tuberculosis, -2024
ANTI-TB (BMBF; VDI-VDE) Targeted nanocarrier for anti-tuberculosis drug delivery (Speaker), -2021
DFG Russia-Germany Correlates of exacerbated and ameliorated pathogenesis in experimental and clinical tuberculosis, -2021
DFG Middle East Cooperation: with Technion, Haifa: Regulatory functions of oxidative/ antioxidative processes during host-pathogen interaction in tuberculosis
VITALITY (https://www.vitality-trial.co.uk); Horizon 2020; EDCTP) Vitamin D for adolescents with HIV to reduce musculoskeletal morbidity and immunpathology: an individually randomised, double-blinded placebo-controlled trial, -2024
ERA4TB (https://era4tb.org; Horizon 2020 IMI): European regimen accelerator for tuberculosis, - 2025
LPI-BT1(Leibniz-Zentrums für Photonik in der Infektionsforschung, Basistechnologie 1): Imaging of tuberculosis and antibiotic nanocarrier, - 2025
PPC-FZB PlasmaplusCorona (BMBF) - Plasmabasierte Desinfektion des Respirationstraktes zur Senkung der SARS-CoV-2 Viruslast in vitro und in vivo
DAAD Stipend (cooperation with IIT Indore): TRPV ion transporters in tuberculosis
Cooperations
Claus Feldmann, KIT, Karlsruhe; Lea Ann Dailey, University Halle; Katharina Schwarz, ITEM, Hannover; Matthias Barz, University Leiden, NL: Targeted nanocarrier for anti-TB drug delivery
Esther Meyron-Holtz, Technion-Israel Institute of Technology, Haifa, Israel: Iron in tuberculosis
John Baines, MPI for Evolutionary Biology, Plön: Microbiota in infection and immunity
Albert Haas, University of Bonn: Trafficking of intracellular bacteria
Albert Sickmann, ISAS, Dortmund; Frank Schmidt, Weill Cornell Medicine, Qatar; Moran Benhar, Technion-Israel Institute of Technology, Haifa, Israel: Proteomics of host - pathogen interactions
Wolfgang Streit, University Hamburg: Mixed biofilms Stenotrophomonas maltophilia
Christine Rhode, Johannes Wittmann, DSMZ, Braunschweig: Phages against Stenotrophomonas maltophilia
Bernhard Hube, Sascha Brunke, HKI, Jena: Candida in mixed bacterial biofilms
Alexander Apt, Vladimir Yeremeev, Central Institute for Tuberculosis, Moscow 107564, Russia; Properties on susceptibility and resistance in tuberculosis
Thomas von Woedtke, Sander Bekeschus, INP, Greifswald: Cold plasma as anti-infection therapy
Avinash Sonawane, IITI, Indore, India: TRPV ion transporters in tuberculosis host responses & new anti TB compounds
Andrea Rachow, LMU, München; Robert Wallis, The Aurum Institute, Johannesburg, SA: Biomarkers for post tuberculosis disease prediction
Natalia Shubladze, Sergo Vashakidze: National Center for TB and Lung Diseases of Georgia, Tiblis, Georgia: Analysis of human tuberculosis patient tissue resections
Daniel Yero, Institut de Biotecnologia i de Biomedicina (IBB), Universitat Autònoma de Barcelona (UAB), Barcelona, Spain; Ralph Bertram, Jörg Steinmann, Institute of Clinical Hygiene, Medical Microbiology and Infectiology, Klinikum Nürnberg, Paracelsus Medical University, Nuremberg: Pathobiology of Stenotrophomonas maltophilia
Andre Franke, CAU Kiel: MHC peptide identification from tuberculosis infected cells
Wolfram Brune; Beatriz Escudero-Perez: LCI funded joined PhD projects (Dallenga)
Projects